THE POTENTIAL CLINICAL-SIGNIFICANCE OF THE ISONIAZID ACETYLATOR PHENOTYPE IN THE TREATMENT OF PULMONARY TUBERCULOSIS

[1] [Anonymous], 1977, Tubercle, V58, P129

[2] [Anonymous], 1975, Tubercle, V56, P81

[3] [Anonymous], 1973, Tubercle, V54, P99

[4] [Anonymous], 1974, Lancet, V2, P1100

[5] [Anonymous], 1973, Tubercle, V54, P23

[6] [Anonymous], 1981, Tubercle, V62, P13

[7] [Anonymous], 1976, Tubercle, V57, P235

[8] ARMSTRONG AR, 1960, AM REV RESPIR DIS, V81, P588

[9] BARTMANN K, 1963, Beitr Klin Tuberk Spezif Tuberkuloseforsch, V127, P546, DOI 10.1007/BF02144625

[10] BERNSTEIN J, 1952, AM REV TUBERC PULM, V65, P357

[1] [Anonymous], 1977, Tubercle, V58, P129

[2] [Anonymous], 1975, Tubercle, V56, P81

[3] [Anonymous], 1973, Tubercle, V54, P99

[4] [Anonymous], 1974, Lancet, V2, P1100

[5] [Anonymous], 1973, Tubercle, V54, P23

[6] [Anonymous], 1981, Tubercle, V62, P13

[7] [Anonymous], 1976, Tubercle, V57, P235

[8] ARMSTRONG AR, 1960, AM REV RESPIR DIS, V81, P588

[9] BARTMANN K, 1963, Beitr Klin Tuberk Spezif Tuberkuloseforsch, V127, P546, DOI 10.1007/BF02144625

[10] BERNSTEIN J, 1952, AM REV TUBERC PULM, V65, P357